Teva is a global pharmaceutical leader and the world's largest generic medicines producer, committed to improving health and increasing access to quality health solutions worldwide Teva is inviting talent to fuel its ambitious growth plans for the year.

PAREXEL has supported the Bio-Tech and Pharmaceutical industries in helping the development of new drugs and treatments on a global basis. As a leading global biopharmaceutical service provider, they supply knowledge-based contract research, medical communications and consulting services across a broad range of therapeutic areas to the worldwide pharmaceutical, biotechnology and medical device industries.

Post : Senior Clinical Research Associate

Translational Health Science and Technology Institute (THSTI) is an autonomous Institute of the Department of Biotechnology, Ministry of Science and Technology, Govt. of India. The institute is an integral part of the interdisciplinary NCR Biotech Science Cluster located at Faridabad, and is designed as a dynamic, interactive organization with the mission to conductinnovative translational research and to develop research collaborations across disciplines and professions to translate concepts into products to improve human health.

Sardar Vallabhbhai National Institute of Technology (SVNIT), Surat in association with Department of Science and Technology (DST), Government of India, has established a NIDHI-TBI (Technology Business Incubator) named ASHINE (Association for Harnessing Innovation and Entrepreneurship). ASHINE, which is a section 8 (not-for-profit) company, aims to promote entrepreneurial activity on SVNIT campus and commercialization of R&D efforts across all disciplines of Engineering and Technology including Energy, Environment and Manufacturing.

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happiness and hope.

Post : Technician / Officer / Sr. Officer

Macleods Pharmaceuticals, fastest growing company was established in 1986. Ranked amongst the top 10 pharma companies with a strength of 20000 employees, operating in 140 plus countries. Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities.

WALK IN DRIVE AT BADDI

Genotypic is a pioneering genomics company since 1998 based in India providing Next Generation Sequencing (NGS), Microarray, Bioinformatics services and solutions to domestic, international pharma, biotech companies and academia. We are best known for simplifying complex genomics and to bridge the gap between biology and technologies. Our high-throughput facilities for genomics with ISO 9001:2015 accreditation is located in Bangalore, India.

The Central Drugs Standard Control Organisation under Directorate General of Health Services,Ministry of Health & Family Welfare,Government of India is the National Regulatory Authority (NRA) of India. Its headquarter is located at FDA Bhawan, Kotla Road, New Delhi 110002 and also has six zonal offices,four sub zonal offices,thirteen Port offices and seven laboratories spread across the country.

Post : TDA (Pharmacovigilance) - 02

CSIR-National Botanical Research Institute (NBRI) – is amongst one of the constituent research institutes of the Council of Scientific and Industrial Research (CSIR), New Delhi. Originally set up as the National Botanic Gardens (NBG) by the State Government of Uttar Pradesh (U.P.), it was taken over by the CSIR in 1953. CSIR- National Botanical Research Institute (NBRI), Lucknow is a constituent laboratory of Council of Scientific & Industrial Research (CSIR). CSIR-NBRI undertakes basic and applied research in important areas of plant sciences.

Established in 1984, the Institute of Microbial Technology (IMTech) is one among the chain of 37 national laboratories, 6 units and 39 outreach centres of the Council of Scientific and Industrial Research. Set-up to be a fore-runner in the niche domain of microbial biotechnology, the Institute in its initial years functioned from a start-up laboratory that provided a truly world-class R&D ambience in an area of over 10,000 sq. ft. to its researchers.

The Central Drugs Standard Control Organisation under Directorate General of Health Services,Ministry of Health & Family Welfare,Government of India is the National Regulatory Authority (NRA) of India. Its headquarter is located at FDA Bhawan, Kotla Road, New Delhi 110002 and also has six zonal offices,four sub zonal offices,thirteen Port offices and seven laboratories spread across the country.

Post : Research Scientist

The Institute of Liver & Biliary Sciences (ILBS) has been established by the Government of the National Capital Territory of Delhi as an autonomous institute, under the Societies act. The mission of ILBS is to become a dedicated international centre of excellence for the diagnosis, management and advanced training and research in the field of liver and biliary diseases.  The first phase of ILBS is already functional having 180 hospital beds, 74 of which cater as intensive care (ICU) beds.

Pharmaceuticals & Medical Devices Bureau of India (PMBI) is the implementing agency for Pradhan Mantri Bhartiya Janaushadhi Pariyojana of Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India. The objective of the scheme is to make available quality generic medicines at affordable prices to all. PMBI is expanding it’s operations and has urgent requirement in Sales & Marketing department.

Post : Assistant Manager / Senior Marketing Officer (Sales & Marketing)

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.

Inviting candidates for OSD manufacturing plant, Ahmedabad

Aculife Healthcare Pvt. Ltd Company is a part of Nirma Group & it is one of world's largest Infusion & Injectable Company, having a State-of-the art manufacturing facility spread over 550 acres of land located near Ahmedabad, Gujarat. Aculife healthcare has global operation in more than 100 countries and it has subsidiaries in Brazil, Mexico & Vietnam. The manufacturing facility has 2 plants with FFS technology, 1 Glass injectable plant and a one dedicated R&D center equipped with advance technology and unmatched research team.

WHO has added the R21/Matrix-M malaria vaccine to its list of prequalified vaccines. In October 2023, WHO recommended its use for the prevention of malaria in children following the advice of the WHO Strategic Advisory Group of Experts (SAGE) on Immunization and the Malaria Policy Advisory Group. The prequalification means larger access to vaccines as a key tool to prevent malaria in children with it being a prerequisite for vaccine procurement by UNICEF and funding support for deployment by Gavi, the Vaccine Alliance.

Takeda announced that LIVTENCITY (maribavir) has been approved by the National Medical Products Administration (NMPA) of China for the treatment of adult patients with post-hematopoietic stem cell transplant (HSCT) or solid organ transplant (SOT) cytomegalovirus (CMV) infection/disease that is refractory to treatment (with or without genotypic resistance) with ganciclovir, valganciclovir, cidofovir or foscarnet. LIVTENCITY is the first and only inhibitor of CMV-specific UL97 protein kinase in China for this indication.

Sanofi is discontinuing the global clinical development program of tusamitamab ravtansine. The decision is based on the outcome of a prespecified interim analysis of the Phase 3 CARMEN-LC03 trial evaluating tusamitamab ravtansine as monotherapy compared to docetaxel in previously treated patients with metastatic non-squamous (NSq) non-small cell lung cancer (NSCLC) whose tumors express high levels of carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5).

FOREMOST MEDITECH has received the award for best promising company for healthcare medical devices by Medgate.

The event was honored with the presence of  Cmdr.Surender Singh War Veteran & Leader BJP who was chief guest. Other guests include Rajiv Nath, Forum coordinator AiMED and Dr Girdhar Gyani, Director General AHPI.